Fondazione Paola Gonzato ETS

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors | New England Journal of Medicine nejm.org/doi/full/10.10…

Stewardship of Osteosarcoma Now has passed to @BardoFoundation. @BHD_Foundation is now registered as a 501c charity in the US. Follow each for updates: x.com/OsteosarcomaNow x.com/BHD_Foundation

Save your spot now! The 16th SPAGN Annual Conference is happening May 1 to 3, 2026 in Stockholm, Sweden. Register today and join advocates, experts, and the global sarcoma community working to make a difference together. Register NOW! sarcoma-patients.org/spagn-annual-c… #SPAGN2026

Honored to speak at today’s ItaCRIN/#ECRIN webinar on the #WHO’s new #ClinicalResearch guidelines, and to highlight #sarcomas as a concrete example in this multistakeholder discussion. @istsupsan @sarcomapatients

🆕new article in press: ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI). @jnkath @mihaela_aldea @BenWestphalen. Read it here: annalsofoncology.org/article/S0923-… 📷

#marginization on #overallsurvival in patients with #STS in #Ontario #Canada. No difference in peri-operative management, but regression analysis noted #lower functional outcomes and #poorer #overallsurvival.

The Physician Who Made Equality His Mission - Jean-Yves Blay's Legacy in Fair Cancer Care - OncoDaily oncodaily.com/magazine/jean-…

New uses for existing drugs offer a faster, smarter way to advance sarcoma treatments. At SPAGN we’re backing reform and non-profit innovation so patients benefit. Our latest blog: sarcoma-patients.org/blog/drug_repu… #Sarcoma #RareCancers #PatientAdvocacy #DrugRepurposing

Our official statement on the discontinued development of brigimadlin, from the SPAGN Board of Directors, Executive Director, and Team.

ONLY TOGETHER In 2016, no one knew what a phyllodes tumor was. Not even the doctors. Today: a national guideline, 2 research studies, a global patient platform, and the first international symposium.

Honored to be at Condor Symposium discussing TME in #Sarcoma #Chondrosarcoma with @AditiDhirMD presenting her results on Vaccine therapy for #Sarcoma patients. @Welcome_UBx @univbordeaux_EN

From the daily catch - an EWSR1::SMAD3 rearranged neoplasm. Michal M, et al EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms. Am J Surg Pathol. 2018 Oct;42(10):1325-1333. PMID: 29957732.

Gastrointestinal stromal tumors of the stomach often have numerous paranuclear vacuoles, which made our forefathers consider them as smooth muscle tumors!

📢 Have you read our new @ASCO Global Geriatric Oncology Guidelines yet? They provide resource-stratified recommendations to improve cancer care for older adults worldwide 🌍👵🧓 Read & download the full manuscript here 👉 doi.org/10.1200/GO-25-… #gerionc #globonc #ASCOGuidelines

Role for Mifamurtide in Primary HG Osteosarcoma? #sec-3" target="_blank" rel="nofollow noopener">ascopubs.org/doi/10.1200/JC… by @ManuPalmerini @SylvesterCancer & @BrotoJavier @fjimenezdiaz -398 pts -5yr EFS 65%, OS 75% -Mif+Chemo 5yr EFS 71%, OS 75% -Chemo only 5yr EFS 58%, OS 66% -Mif may⬆️ 5yr EFS by 13% & OS by 9% -MVA P=.06

Hot off the press: 'How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancer' - our new paper on tackling drug development in ultra-rare sarcomas. authors.elsevier.com/a/1laWW15X3%7E…

Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registry - The Lancet Regional Health – Europe thelancet.com/journals/lanep…

We are stronger together. SPAGN is a network of nearly 70 national patient advocacy groups specializing in different subtypes of sarcomas. Do you represent a sarcoma advocacy group? Visit bit.ly/SPAGNmembers to learn more about membership. #SarcomaAwarenessMonth2025

A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wall in @ESMO_Open. High degree of agreement, high-risk pts by either tool had improved outcomes with (N)A chemo. esmoopen.com/article/S2059-…

Sarcomas can be isolating, but you are not alone. Three tips: 1️⃣ Find a patient support group near you at bit.ly/SPAGNmembers 2️⃣ Join patient support groups on social media 3️⃣ Share your story, what questions to ask, and what worked for you. #SarcomaAwarenessMonth2025